Last updated on July 2018

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)


Brief description of study

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma

Clinical Study Identifier: NCT02684006

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Ballarat Day Procedure Centre
Wendouree, Australia

Pfizer CT.gov Call Center

Ballarat Oncology & Haematology Services
Wendouree, Australia

Pfizer CT.gov Call Center

Nova Pharmacy
Wendouree, Australia

Pfizer CT.gov Call Center

Lake Imaging
Ballarat, Australia
3.15miles